Blog

Insulet PODD is well-poised to grow in the upcoming quarters, owing to its strong momentum for the Omnipod 5 automated insulin delivery (“AID”) system for both Type 1 and Type 2 populations. The

The Federal Reserve has proposed easing post-crisis capital rules for U.S. banks, aiming to encourage lending while maintaining system stability. Large institutions such as JPMorgan JPM and Bank of

Sally Beauty Holdings, Inc. SBH is expanding deeper into social commerce with the launch of its TikTok Shop storefront, adding another channel to its digital ecosystem. The move reflects the

In a significant shift from its long-standing workforce reduction practices, The Goldman Sachs Group, Inc. GS is set to roll out a layoff strategy in 2026, one that replaces large, one-time job cuts

D-Wave Quantum QBTS or “D-Wave” has maintained a dual platform approach for the past five years, positioning itself as a one-stop shop for addressing a full range of complex customer problems. On

Paychex, Inc. PAYX will release third-quarter fiscal 2026 results on March 25, before market open.

PAYX’s earnings outperformed the Zacks Consensus Estimate in four preceding quarters, with an

Shares of Crimson Wine Group, Ltd CWGL have lost 3.1% since reporting results for 2025, underperforming the S&P 500 index’s 1% dip over the same period. The weakness extends to a broader horizon

T. Rowe Price Group, Inc. TROW and Oak Hill Advisors (“OHA”) have announced the launch of the T. Rowe Price OHA Flexible Credit Income Fund (OFLEX). The move marks another step in their efforts to

Chicago Atlantic Real Estate Finance, Inc. (REFI) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the

Investors might want to bet on Afya (AFYA), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this

Rising market volatility, pro-growth U.S. economic policies under President Donald Trump, broader acceptance of digital assets, ongoing diversification efforts by exchanges beyond core trading

Croda International PLC Unsponsored ADR (COIHY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in

GigaCloud Technology Inc. (GCT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates

BWX Technologies (BWXT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

Hugo Boss (BOSSY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of

Angel Studios, Inc. (ANGX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

Theravance Biopharma (TBPH) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful

Cognex Corporation (CGNX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in

Chicago Atlantic Real Estate Finance, Inc. (REFI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in

VeriSign (VRSN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most

Tokyo Electron Ltd. (TOELY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates

Shares of Protagonist Therapeutics PTGX have gained nearly 7% over the past week. The upside came after the company announced that the FDA had approved its partner, Johnson & Johnson JNJ’s

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your